BRCA1 and ovarian cancer: Notably, the expression levels of EGFR were markedly increased (Figure 2F, P < 0.05), along with a hypermethylated promoter-mediated BRCA1 deficiency in ovarian cancer (Figure 2E, P < 0.05).